Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs Wheaton Precious Metals Corp (WPM) Price & Performance

Citius Pharmaceuticals IncTrade
Wheaton Precious Metals CorpTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs Wheaton Precious Metals Corp — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Wheaton Precious Metals Corp trades at $138 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 3045.5× Citius Pharmaceuticals Inc's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CTXRWPM
Market Cap
$20.01M$60.94B
Sector
HealthBasic Materials
52-Week High
$1.82$165.72
52-Week Low
$0.48$91.02
Enterprise Value
$16.23M$62.82B
Dividend Yield
0.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citius Pharmaceuticals Inc

No Aura AI signal available yet.

Wheaton Precious Metals Corp

Wheaton Precious Metals (WPM) trades at $133.39, down 0.6% for the day, with a bullish technical signal driven by moving averages despite overbought RSI readings. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.19, supported by higher metal prices and sales volumes. Revenue surged to $2.31 billion in 2025, with net income reaching $1.47 billion, reflecting robust profitability margins.

The outlook remains positive with an 80% analyst buy rating and a $161.75 consensus price target, indicating ~21% upside. Key risks include reliance on commodity prices and projected negative cash flow in 2026. The stock's premium valuation (P/E 29.82) requires sustained earnings growth to justify further gains.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About Wheaton Precious Metals Corp

Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.

Read more on WPM